Abstract Background Fructus Forsythiae, a pivotal material in Traditional Chinese Medicine, possesses confirmed anti-inflammatory, antiviral, and cardioprotective effects, which are crucial for managing cardiovascular inflammatory conditions. Its bioactive constituents, such as forsythiasides, have demonstrated therapeutic potential in treating viral myocarditis and other inflammation-related heart diseases. Despite its wide use, the medicinal quality of Fructus Forsythiae frequently suffers from inconsistency due to environmental variations, which directly compromises clinical efficacy and challenges reliable cardiovascular treatment. Current research lacks systematic investigation into how ecological variables modulate its bioactive constituents. Purpose This study aimed to address this research gap by establishing optimized cultivation techniques to ensure a reliable, standardized supply of Fructus Forsythiae, essential for consistent cardiac therapeutic outcomes. Subjects and Methods We conducted germplasm surveys across Chongqing, China, collecting 88 standardized fruit samples from diverse topographical gradients. Using a fully validated High Performance Liquid Chromatography (HPLC) method, we simultaneously quantified four key bioactive markers: forsythiaside A, forsythiaside B, forsythin, and phillygenin. The relationship between the accumulation of these four components and the ecological factors of their origin was then systematically analyzed using chemometric modeling, specifically Principal Component Analysis (PCA) and Orthogonal Partial Least Squares-Discriminant Analysis (OPLS-DA). This analysis aimed to build a quality-control model that supports reliable cardiovascular efficacy and drug standardization for heart-related treatments. Results The quantitative determination revealed substantial inter-quadrat variability in the content of the four phytochemical markers, with phillygenin exhibiting the most pronounced variation (RSD=59.4%). Chemometric analysis confirmed that altitude was the dominant ecological factor modulating the phytochemical profile. Specifically, forsythin content showed a significant and strong positive correlation with elevation, reaching its peak accumulation at 1300-1500 meters. In contrast, forsythiasides A and B exhibited a bimodal accumulation pattern with elevated levels observed at two distinct altitudinal ranges (400-500 m and 1200-1300 m). OPLS-DA identified forsythiaside B and phillygenin (VIP 1.0) as key discriminators, providing a scientific basis for standardizing quality to meet cardiovascular pharmacodynamic requirements, particularly for anti-inflammatory heart therapy. Conclusions This study establishes that the phytochemical quality of Fructus Forsythiae is profoundly and predictably influenced by its cultivation environment, with altitude being the most critical factor. We recommend optimizing cultivation altitude (1200-1300 m) and slope aspects to standardize its pharmacopeial quality. These targeted cultivation strategies ensure a consistent supply of key anti-inflammatory compounds, directly supporting the reliability of Fructus Forsythiae in treating cardiovascular inflammatory diseases such as viral myocarditis. By addressing chemical variability, this research enhances therapeutic trust and contributes directly to improved cardiac health outcomes and drug development for heart conditions.
Chu et al. (Thu,) studied this question.